A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion (Q33504409)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion |
scientific article |
Statements
1 reference
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion (English)
1 reference
L Paz-Ares
1 reference
R Kunka
1 reference
D DeMaria
1 reference
J Cassidy
1 reference
M Alden
1 reference
P Beranek
1 reference
S Kaye
1 reference
D Littlefield
1 reference
D Reilly
1 reference
S Depee
1 reference
P Wissel
1 reference
C Twelves
1 reference
P O'Dwyer
1 reference
1 November 1998
1 reference
1 reference
1329-1336
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference